Electromed, Inc. to Report Q1 Fiscal 2027 Financial Results on November 10, 2026
Electromed (ELMD) will release its fiscal 2027 first-quarter financial results on November 10, 2026, after the stock market closes.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Interested parties may participate in the call by dialing (877) 407-3982 (Toll Free) or (201) 493-6780.
The live webcast of the call will be accessible in the Investor Relations section of Electromed’s website and directly via the following link: Electromed's Q1 Fiscal 2027 Earnings Call
For those who cannot listen to the live broadcast, a replay will be available by dialing (844) 512-2921 (Toll Free) or (412) 317-6671 and referencing Access ID 13763053. Additionally, a replay of the webcast will be available in the Investor Relations section of Electromed’s web site at: Events & Presentations
About Electromed, Inc.
Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota, and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.
Source: Electromed, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261027366879/en/
Brad Nagel, Chief Financial Officer
(952) 758-9299
investorrelations@electromed.com
Mike Cavanaugh, Investor Relations
ICR Healthcare
(617) 877-9641
mike.cavanaugh@icrhealthcare.com
Source: Electromed, Inc.